Open AccessPrimary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical Sciences
Author(s) -
Mukesh Patekar,
Narayan Prasad Adhikari,
Ahitagni Biswas,
Vinod Raina,
Lalit Kumar,
Bidhu Kalyan Mohanti,
Ajay Gogia,
Atul Sharma,
Atul Batra,
Sameer Bakhshi,
Ajay Garg,
Sanjay Thulkar,
Meher Chand Sharma,
Sreenivas Vishnubhatla,
Saphalta Baghmar,
Ranjit Kumar Sahoo
Publication year - 2019
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.18.00124
Subject(s) - medicine , procarbazine , rituximab , methotrexate , lymphoma , population , primary central nervous system lymphoma , vincristine , surgery , retrospective cohort study , chemotherapy , pediatrics , cyclophosphamide , environmental health
The information about the outcome of primary CNS lymphoma (PCNSL) in India is scarce, because there is no population-based or large hospital-based data.